Prevention of cyclosporine-induced nephrotoxicity by clenbuterol, a beta 2-adrenoreceptor stimulant.
Ishikawa
A
A
Hamamatsu University School of Medicine, Japan.
Fujita
K
K
D000318:Adrenergic beta-Agonists / Q000494:pharmacology*; D000818:Animals; D002976:Clenbuterol / Q000494:pharmacology*; D003404:Creatinine / Q000097:blood; D016572:Cyclosporine / Q000037:antagonists & inhibitors / Q000633:toxicity*; D007166:Immunosuppressive Agents / Q000037:antagonists & inhibitors / Q000633:toxicity*; D007668:Kidney / Q000187:drug effects* / Q000473:pathology / Q000502:physiology; D007672:Kidney Cortex / Q000098:blood supply; D008297:Male; D011188:Potassium / Q000097:blood; D051381:Rats; D017208:Rats, Wistar; D012039:Regional Blood Flow / Q000187:drug effects
D000318:Adrenergic beta-Agonists; D007166:Immunosuppressive Agents; D016572:Cyclosporine; D003404:Creatinine; D011188:Potassium; D002976:Clenbuterol